Cavernoma Surgery Indications

General Indications for Surgical Resection

The American Association of Neurological Surgeons recommends that surgical resection of cavernomas is primarily indicated for symptomatic hemorrhages, medically refractory epilepsy, and brainstem cavernomas after a second symptomatic hemorrhage 1, 2
Surgical resection is not generally recommended for asymptomatic cavernomas, especially those located in eloquent, deep, or brainstem regions, or in cases of multiple asymptomatic cavernomas 1, 3
For symptomatic, easily accessible cavernomas, surgical resection is indicated due to the increased risk of rebleeding after the first hemorrhage and the low morbidity associated with the operation 2, 4
Early surgical resection should be considered for cavernomas that cause epilepsy, particularly in cases of medically refractory epilepsy 5

Surgical resection of solitary asymptomatic cavernomas may be considered if they are easily accessible in non-eloquent areas 1, 3
Reasons for surgery may include prevention of future hemorrhages, psychological burden, costly and time-consuming follow-up, facilitation of lifestyle or career decisions, or in patients who may require anticoagulation 3

For deep cavernomas (insular, basal ganglia, thalamus), surgical resection may be considered if they are symptomatic or have bled previously 6
Postoperative morbidity for these locations ranges from 5-18% with a mortality rate of up to 2% 4
The morbidity and mortality risk is equivalent to the risk of living with the cavernoma for 5-10 years 6

After a second symptomatic hemorrhage, surgical resection of brainstem cavernomas is appropriate due to their potentially more aggressive course 4
Early postoperative morbidity for brainstem cavernomas is significant, affecting almost 50% of cases 4, 7
The indication for resection after a single disabling hemorrhage is weaker 8
For asymptomatic brainstem cavernomas, conservative treatment is recommended, as the natural risk of death or non-fatal stroke is approximately 2.4% over 5 years, compared to 6% after surgical resection 7

The risk of rebleeding after the first hemorrhage is 29.5% over 5 years 4
Surgical resection is indicated for patients with recurrent symptomatic hemorrhages 7

For cavernomas that cause epilepsy, early surgical resection should be considered, particularly in cases of medically refractory epilepsy 5
Approximately 50-60% of patients become seizure-free under medical therapy after the first diagnosis of cavernoma-related epilepsy 5

Stereotactic radiosurgery may be considered for solitary cavernomas with prior symptomatic hemorrhage if the cavernoma is located in eloquent areas with an unacceptably high surgical risk 9, 7
Radiosurgery is not recommended for asymptomatic cavernomas, surgically accessible cavernomas, or familial cavernomas due to concerns about the development of new cavernomas 10, 7
The recommended prescription dose for stereotactic radiosurgery is between 11-13 Gy to reduce the risk of radiation-induced side effects 7